Biotin Works Cited

  1. Therapeutic Research Faculty. Biotin: Full Monograph. Natural Medicines Comprehensive Database. 2010. Full Monograph..
  2. Gropper, Sareen S., Smith, Jack L. and Groff, James L. Advanced Nutrition and Human Metabolism. 5th. Belmont: Wadsworth: Cengage Learning, 2008. ISBN-13: 978-0-495-11657-8.
  3. Klatz, Ronald. The Official Anti-Aging Revolution: Stop the Clock Time Is on Your Side for a Younger, Stronger, Happier You. s.l.: CreateSpace, 2009. ISBN-13: 978-1-4587-2210-2.
  4. Lord, Richard S., Lord, Richard S. and Bralley, J. Alexander. Laboratory Evaluations for Integrative and Functional Medicine. Duluth: Metametrix Institute, 2008. ISBN: 0-9673949-4-5.
  5. Higdon, Jane, Drake, Victoria J. and Mock, Donald. Micronutrient Information Center: Biotin. Oregon State University: Linus Pauling Institute. [Online] August 2008. [Cited: November 6, 2014.] .
  6. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  7. Biotin and biotinidase deficiency. Zempleni, Janos, Hassan, Yousef I. and Wijeratne, Subhashinee S.K. [ed.] Kjell Öberg. 6, Uppsala: Informa Plc, November 1, 2008, Expert Review of Endocrinology & Metabolism, Vol. 3, pp. 715-724. ISSN: 1744-6651.
  8. The Potential Role of Biotin Insufficiency on Essential Fatty Acid Metabolism and Cardiovascular Disease Risk. Ho, Richard C. and Cordain, Loren. [ed.] Ranjit Chandra. 8, Newfoundland: Elsevier Inc., August 2000, Nutrition Research, Vol. 20, pp. 1201-1212. DOI: 10.1016/S0271-5317(00)00201-3; ISSN: 0271-5317.
  9. Invitrogen. Avidin and NeutrAvidinô Biotin-Binding Proteins and Conjugates. 2009. pp. 1-5. MP 00887.
  10. Biotinidase Deficiency. Wolf, Barry. [ed.] R.A. Pagon, et al., et al. Seattle: University of Washington, December 5, 2013, GeneReviews®. Bookshelf ID: NBK1322; PMID: 20301497.
  11. Mangels, Reed, Messina, Virginia and Messina, Mark. The Dietitian's Guide to Vegetarian Diets: Issues and Applications. Burlington: Jones & Bartlett Learning, LLC, 2011. ISBN-13: 978-0-7637-7976-4.
  12. Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis. Lazzeri, Elena, et al., et al. [ed.] Ignasi Carrió. 11, Barcelona: Springer-Verlag, November 1, 2004, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, pp. 1505-1511. DOI: 10.1007/s00259-004-1581-2; ISSN: 1619-7070.
  13. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein. Luo, D., Rogers, C.N., Steed, J.T., Gilliam, L.K., Hampe, C.S., Lernmark, A. [ed.] Alf Pühler. 1, Bielefeld: Elsevier B.V., July 1, 2004, Journal of Biotechnology, Vol. 111, pp. 97-104. DOI: 10.1016/j.jbiotec.2004.03.009; ISSN: 0168-1656.
  14. Mayo Foundation for Medical Education and Research. Unit Code 84221: Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid. Mayo Medical Laboratories. [Online] [Cited: November 7, 2014.] Test ID: GD65C.
  15. Röhn, Till A. and Bachmann, Martin F. Tuning the Immune Response to Our Advantage: Design of Vaccines with Tailored Functions. [ed.] Yury E . Khudyakov. Medicinal Protein Engineering. Boca Raton: CRC Press: Taylor & Francis Group, 2008, 6, pp. 123-142. ISBN: 978-0-8493-7368-8.
  16. Verret, D.J. Patient Guide to Hair Loss & Hair Restoration. Plano: WJ Sonnier Publishing, 2009. ISBN: 978-0-578-01492-0.
  17. In vitro methodology, hormonal and nutritional effects and fibre production in isolated ovine and caprine anagen hair follicles. Galbraith, H. [ed.] Michel Doreau. 9, Clermont-Ferrand: Cambridge University Press, September 2010, Animal, Vol. 4, pp. 1482-1489. DOI: 10.1017/S1751731109991595; ISSN: 1751-7311.
  18. Mock, Donald M. Biotin. [ed.] Maurice Edward Shils and Moshe Shike. Modern Nutrition in Health and Disease. 10th. Baltimore; Philadelphia: Lippincott Williams & Wilkins, 2006, 30, pp. 498-506. ISBN: 0-7817-4133-5.
  19. Mindell, Earl and Hopkins, Virginia. Doctor Earl Mindell's The Power of MSM. New York: McGraw-Hill Professional, 2002. ISBN: 0-658-01460-9.
  20. Bergfeld, Wilma F. Telogen Effluvium. [ed.] Amy J. McMichael and Maria K. Hordinsky. Hair and Scalp Diseases. New York: Informa Healthcare USA, Inc., 2008, 9, pp. 119-136. ISBN-10: 1-57444-822-6.
  21. Case Reports: Multiple Carboxylase Deficiency. Apte, B.N. and Tibrewala, V.N. 1, Mumbai: Bombay Hospital Institute of Medical Sciences, January 2001, Bombay Hospital Journal, Vol. 43. ISSN: 0524-0182.
  22. Low serum biotinidase activity in children with valproic acid monotherapy. Schulpis, K.H., Karikas, G.A., Tjamouranis, J., Regoutas, S., Tsakiris, S. [ed.] Timothy A. Pedley. 10, New York: Wiley-Blackwell Inc., 2001 October, Epilepsia, Vol. 42, pp. 1359-1362. eISSN: 1528-1167.
  23. Zinc and biotin deficiencies after pancreaticoduodenectomy. Yazbeck, N., Muwakkit, S., Abboud, M., Saab, R. [ed.] Pierre H. Deprez. 2, Louvain-la-Neuve: Universa Press, April-June 2010, Acta Gastro-Enterologica Belgica, Vol. 73, pp. 283-286. ISSN: 1784-3227.
  24. Lintner, Karl. Peptides and proteins. [ed.] Zoe D. Draelos. Cosmetic Dermatology: Products and Procedures. Chichester: Blackwell Publishing Ltd, 2010, 36, pp. 292-301. ISBN: 978-1-4051-8635-3.
  25. Merz Pharmaceuticals, Inc. Clinical Studies - Appearex®. 2006.
  26. Gittleman, Ann Louise and Castro, Ann. The Living Beauty Detox Program: The Revolutionary Diet for Each and Every Season of a Woman's Life. New York: HarperCollins, 2001. ISBN: 0-06-251627-2.
  27. Final Report on the Safety Assessment of Biotin. International Journal of Toxicology (Taylor & Francis). s.l.: Taylor & Francis Ltd., 2001, Vol. 20. 10915818.
  28. Transport of Biotin in Human Keratinocytes. Grafe, Franziska, et al., et al. [ed.] Lowell A. Goldsmith. 3, Chapel Hill: Nature Publishing Group, March 2003, Journal of Investigative Dermatology, Vol. 120, pp. 428-433. DOI: 10.1046/j.1523-1747.2003.12058.x; ISSN: 0022-202X.
  29. Final Report on the Safety Assessment of Biotin. Fiume, Monice Z. [ed.] Harihara Mehendale. 4 suppl, Monroe: American College of Toxicology, January 2001, International Journal of Toxicology, Vol. 20, pp. 1-12. ISSN: 1091-5818.
  30. Brittle nail syndrome: A pathogenesis-based approach with a proposed grading system. Kerkhof, Peter C. M. van de, et al., et al. [ed.] Jeffrey D. Bernhard. 4, Shrewsbury: Elsevier Inc., October 2005, Journal of the American Academy of Dermatology, Vol. 53, pp. 644-651. DOI: 10.1016/j.jaad.2004.09.002; ISSN: 0190-9622.
  31. Current Status of Therapy of Solid Tumors. Jhanwar, Yuliya S. and Divgi, Chaitanya. [ed.] Heinrich R. Schelbert. 1 suppl, Los Angeles: Society of Nuclear Medicine and Molecular Imaging, January 1, 2005, The Journal of Nuclear Medicine, Vol. 46, pp. 1415-1505. ISSN: 0161-5505.
  32. Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin. Paganelli, Giovanni, et al., et al. [ed.] Ignasi Carrió. Barcelona: Springer-Verlag, February 1, 2010, European Journal of Nuclear Medicine and Molecular Imaging, pp. 203-211. DOI: 10.1007/s00259-009-1260-4; ISSN: 1619-7070.
  33. A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. Bussolati, G., et al., et al. [ed.] Robin Weiss. 7, London: Nature Publishing Group, April 11, 2005, British Journal of Cancer, Vol. 92, pp. 1261-1267. DOI: 10.1038/sj.bjc.6602507; ISSN: 0007-0920.
  34. Adipose tissue engineering with cells in engineered matrices. Flynn, Lauren and Woodhouse, Kimberly A. [ed.] Jamie A Davies. 4, Edinburgh: Taylor & Francis, Oct-Dec 2008, Organogenesis, Vol. 4, pp. 228-235. DOI: 10.4161/org.4.4.7082; ISSN: 1547-6278.
  35. Effect of Avidin and Biotin in Attachment of Human Adipose Stem Cells to Micronized Acellular Dermal Matrix. Yoo, G., Rhie, J.W., Lim, J.S. [ed.] Kap Sung Oh. 1, Seoul: Korean Society of Plastic and Reconstructive Surgeons, January 2008, Journal of the Korean Society of Plastic and Reconstructive Surgeons, Vol. 35, pp. 1-6. ISSN: 1015-6402.
  36. Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein. Forero-Torres, Andres, et al., et al. [ed.] Robert K. Oldham and Donald J. Buchsbaum. 4, Birmingham; Key West: Mary Ann Liebert Inc, August 2005, Cancer Biotherapy & Radiopharmaceuticals, Vol. 20, pp. 379-390. DOI: 10.1089/cbr.2005.20.379; ISSN: 1084-9785.
  37. Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide. Bartolomei, M., et al., et al. [ed.] Giovanni Lucignani. 3, Milan: Edizioni Minerva Medica, September 2004, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, pp. 220-228. ISSN: 1824-4785.
  38. Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study. Grana, C., et al., et al. [ed.] Robin Weiss. 2, London: Nature Publishing Group, January 21, 2002, British Journal of Cancer, Vol. 86, pp. 207-212. DOI: 10.1038/sj.bjc.6600047; ISSN: 0007-0920.
  39. Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL). Weiden, Paul L. and Breitz, Hazel B. [ed.] Matti S. Aapro. 1, Genolier: Elsevier Science Ireland Ltd., October 2001, Critical Reviews in Oncology / Hematology, Vol. 40, pp. 37-51. DOI: 10.1016/S1040-8428(01)00133-0; ISSN: 1040-8428.
  40. A Novel Platform for Radioimmunotherapy: Extracorporeal Depletion of Biotinylated and 90Y-Labeled Rituximab in Patients with Refractory B-Cell Lymphoma. Lindén, Ola, et al., et al. [ed.] Robert K. Oldham and Donald J. Buchsbaum. 4, Birmingham; Key West: Mary Ann Liebert Inc, August 22, 2005, Cancer Biotherapy & Radiopharmaceuticals, Vol. 20, pp. 457-466. DOI: 10.1089/cbr.2005.20.457; ISSN: 1084-9785.
  41. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Albarracin, C.A., Fuqua, B.C., Evans, J.L., Goldfine, I.D. [ed.] Jesse Roth. 1, Manhasset: John Wiley & Sons, Ltd., January 2008, Diabetes/Metabolism Research and Reviews, Vol. 24, pp. 41-51. DOI: 10.1002/dmrr.755; ISSN: 1520-7552.
  42. The Effect of Chromium Picolinate and Biotin Supplementation on Glycemic Control in Poorly Controlled Patients with Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-Blinded, Randomized Trial. Singer, Gregory M. and Geohas, Jeff. [ed.] Satish K. Garg. 6, Denver: Mary Ann Liebert, Inc., December 2006, Diabetes Technology & Therapeutics, Vol. 8, pp. 636-643. DOI: 10.1089/dia.2006.8.636; ISSN: 1520-9156.
  43. Zieve, David and Eltz, David R. HbA1c. Medline Plus: U.S. National Library of Medicine. August 5, 2014. [Cited: November 13, 2014.]
  44. Pharmacological Biotin Supplementation Maintains Biotin Status and Function in Rats Administered Dietary Carbamazepine. Rathman, Sara C., Jesse F. Gregory, III and McMahon, Robert J. [ed.] John W. Suttie. 9, Bethesda: American Society for Nutritional Sciences, September 1, 2003, The Journal of Nutrition, Vol. 133, pp. 2857-2862. ISSN: 0022-3166.
  45. Nutritional supplements, foods, and epilepsy: Is there a relationship? Asadi-Pooya, Ali A., Mintzer, Scott and Sperling, Michael R. [ed.] Philip A. Schwartzkroin and Simon D. Shorvon. 11, Sacramento; London: Wiley Periodicals, Inc., November 2008, Epilepsia, Vol. 49, pp. 1819-1827. DOI: 10.1111/j.1528-1167.2008.01678.x; eISSN: 1528-1167.
  46. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Revilla-Monsalve, Cristina, et al., et al. [ed.] Haim Tapiero, Kenneth D. Tew and Gerald Batist. 4, Châtenay-Malabry; Charleston; Montreal: Elsevier Masson SAS, May 2006, Biomedicine & Pharmacotherapy, Vol. 60, pp. 182-185. DOI: 10.1016/j.biopha.2006.03.005; ISSN: 0753-3322.
  47. Combination of Chromium and Biotin Improves Coronary Risk Factors in Hypercholesterolemic Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-Blind Randomized Clinical Trial. Albarracin, Cesar, et al., et al. [ed.] James R. Sowers. 2, Columbia: John Wiley & Sons, Inc., Spring 2007, Journal of the CardioMetabolic Syndrome, Vol. 2, pp. 91-97. DOI: 10.1111/j.1559-4564.2007.06366.x; eISSN: 1559-4572.
  48. Chromium Picolinate and Biotin Combination Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial. Geohas, Jeff, et al., et al. [ed.] David W. Ploth. 3, Charleston: Lippincott Williams & Wilkins, March 2007, American Journal of the Medical Sciences, Vol. 333, pp. 145-153. DOI: 10.1097/MAJ.0b013e318031b3c9; ISSN: 0002-9629.
  49. Effects of Vitamin-B Complex Supplementation on Periodontal Wound Healing. Neiva, Rodrigo F., et al., et al. [ed.] Robert Genco. 7, Buffalo: American Academy of Periodontology, July 2005, Journal of Periodontology, Vol. 76, pp. 1084-1091. DOI: 10.1902/jop.2005.76.7.1084; eISSN: 1600-051X.
  50. Spinal Cord Demyelination Associated with Biotinidase Deficiency in 3 Chinese Patients. Yang, Yanling, et al., et al. [ed.] Roger A. Brumback. 2, Omaha: SAGE Publications , February 2007, Journal of Child Neurology, Vol. 22, pp. 156-160. DOI: 10.1177/0883073807300307; ISSN: 0883-0738.
  51. Judge, M.R., McLean, W.H.I. and Munro, C.S. Disorders of Keratinization. [ed.] Tony Burns, et al., et al. Rook's Textbook of Dermatology. 8. 8. Chichester: Wiley-Blackwell, 2010, Vol. 1, 19, pp. 19.1-19.122. ISBN: 978-1-4051-6169-5.
  52. Marginal Biotin Deficiency is Common in Normal Human Pregnancy and Is Highly Teratogenic in Mice. Mock, Donald M. [ed.] A. Catharine Ross. 1, University Park: American Society for Nutrition, January 2009, Journal of Nutrition, Vol. 139, pp. 154-157. DOI: 10.3945/jn.108.095273; ISSN: 0022-3166.
  53. Onstad, Dianne. The Vitamin Companion. s.l.: Straight from the Garden, 2004. ISBN: 0-9742211-1-2 0.
  54. Paige, D.G., Gennery, A.R. and Cant, A.J. The Neonate. [ed.] Tony Burns, et al. Rook's Textbook of Dermatology. 8. Chichester: Wiley-Blackwell, 2010, 17, pp. 17.1-17.85. ISBN: 978-1-4051-6169-5.
  55. Tannis, Allison. Feed Your Skin, Starve Your Wrinkles: Eat Your Way to Firmer, More Beautiful Skin with the 100 Best Anti-Aging Foods. s.l.: Fair Winds, 2009. ISBN-13: 978-1-59233-342-4.
  56. Acosta, Phyllis B. Nutrition Management of Patients With Inherited Metabolic Disorders. Sudbury: Jones & Bartlett Learning, 2010. ISBN-13: 978-0-7637-5777-9.
  57. Biotin Responsive Multiple Carboxylase Deficiency Presenting as Diabetic Ketoacidosis. Hou, Jia-Woei. [ed.] Fu-Chan Wei and Jan-Kan Chen. 2, Gueishan Township: Chia-Chu Pao, February 2003, Chang Gung Medical Journal, Vol. 27, pp. 129-132. ISSN: 2319-4170.
  58. Biotin Is Endogenously Expressed in Select Regions of the Rat Central Nervous System. McKay, Bruce E., Molineux, Michael L. and Turner, Ray W. [ed.] Clifford B. Saper. 1, Boston: Wiley-Liss, Inc., May 17, 2004, Journal of Comparative Neurology, Vol. 473, pp. 86-96. DOI: 10.1002/cne.20109; eISSN: 1096-9861.
  59. Biotin-responsive basal ganglia disease: a novel entity. Ozand, P. T., et al., et al. [ed.] Alastair Compston. 7, Cambridge: Oxford University Press: Guarantors of Brain, December 2010, Brain: A Journal of Neurology, Vol. 121, pp. 1267-1279. DOI: 10.1093/brain/121.7.1267; ISSN: 0006-8950.
  60. Movement disorders and inborn errors of metabolism in adults: A diagnostic approach. Sedel, F., et al., et al. [ed.] J. Zschocke and K.M. Gibson. 3, Heidelberg: Springer Netherlands, May 30, 2008, Journal of Inherited Metabolic Disease, Vol. 31, pp. 308-318. DOI: 10.1007/s10545-008-0854-5; ISSN: 0141-8955.
  61. Biotin-Responsive Basal Ganglia Disease Maps to 2q36.3 and Is Due to Mutations in SLC19A3. Zeng, Wen-Qi, et al., et al. [ed.] Stephen T. Warren. 1, Atlanta: Elsevier Inc., July 2005, American Journal of Human Genetics, Vol. 77, pp. 16-26. DOI: 10.1086/431216; ISSN: 0002-9297.
  62. Sorting Out Subacute Encephalopathy. Neary, David and Snowden, Julie S. [ed.] Charles Warlow. 5, Edinburgh: Blackwell Publishing, October 2003, Practical Neurology, Vol. 3, pp. 268-281. eISSN: 1474-7766.
  63. Biotin-Responsive Basal Ganglia Disease in Ethnic Europeans With Novel SLC19A3 Mutations. Debs, Rabab, et al., et al. [ed.] Roger N. Rosenberg. 1, Dallas: American Medical Association, January 2010, Archives of Neurology, Vol. 67, pp. 126-130. DOI: 10.1001/archneurol.2009.293; ISSN: 0003-9942.
  64. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, ²-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability. Fenech, Michael, et al., et al. [ed.] Curtis C. Harris. 5, Bethesda: Oxford University Press, May 2005, Carcinogenesis, Vol. 26, pp. 991-999. DOI: 10.1093/carcin/bgi042; ISSN: 0143-3334.
  65. Bowling, Allen C. Complementary and Alternative Medicine and Multiple Sclerosis. 2nd. New York: Demos Medical Publishing, LLC, 2007. ISBN-13: 978-1-932603-54-5.
  66. In Vivo Biotin Supplementation at a Pharmacologic Dose Decreases Proliferation Rates of Human Peripheral Blood Mononuclear Cells and Cytokine Release. Zempleni, Janos, Helm, Ricki M. and Mock, Donald M. [ed.] John W. Suttie. 5, Bethesda: American Society for Nutritional Sciences, May 1, 2001, The Journal of Nutrition, Vol. 131, pp. 1479-1484. ISSN: 0022-3166.
  67. Retinoic Acid and Affective Disorders: The Evidence for an Association. Bremner, J. Douglas, Shearer, Kirsty and McCaffery, Peter. [ed.] Alan J. Gelenberg. 1, Hershey: Physicians Postgraduate Press, Inc., January 2012, The Journal of Clinical Psychiatry, Vol. 73, pp. 37-50. DOI: 10.4088/JCP.10r05993; ISSN: 0160-6689.
  68. Houston, Mark C. Hypertension: Nutrition, Nutraceuticals, Vitamins, Antioxidants, and Minerals in Prevention and Treatment. [ed.] Ingrid KohlstadtAdvancing Medicine with Food and Nutrients. 2nd. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2012, 6, pp. 105-134. ISBN: 978-1-4398-8772-1.
  69. Torkos, Sherry. The Canadian Encyclopedia of Natural Medicine. Mississauga: John Wiley and Sons Canada, Ltd., 2008. ISBN: 978-0-470-83908-9.
  70. Pressman, Alan H. and Buff, Sheila. The Complete Idiot's Guide to Vitamins and Minerals. New York: Alpha Books: Macmillan, Inc., 1997. ISBN: 0-02-862116-6.
  71. Balch, Phyllis A. Prescription for Nutritional Healing: A Practical A-To-Z Reference to Drug-Free Remedies. 4. New York: Penguin Group (USA) Inc., 2008. ISBN: 1-4362-8219-5.
  72. Kouris-Blazos, Antigone. Drug-nutrient-herb interactions for commonly prescribed medications. [ed.] Vicki Kotsirilos. A Guide to Evidence-Based Integrative and Complementary Medicine. Chatswood: Churchill Livingstone: Elsevier Australia, 2011, Appendix 2, pp. 901-922. ISBN: 978-0-7295-3908-1.
  73. Boullata, Joseph I. An Introduction to Drug-Nutrient Interactions. [ed.] Joseph I. Boullata and Vincent T. Armenti. Handbook of Drug-Nutrient Interactions. New York: Humana Press: Springer Science-Business Media, LLC, 2010, 1, pp. 3-26. ISBN: 978-1-60327-363-3; DOI: 10.1007/978-1-60327-362-6.
  74. Berdanier, Carolyn D. Nutrient-Nutrient Interactions. [ed.] Carolyn D. Berdanier, Elaine B. Feldman and Johanna Dwyer. Handbook of Nutrition and Food. 2nd. Boca Raton: CRC Press: Taylor & Francis Group, 2008, 11, pp. 221-226. ISBN-13: 978-0-8493-9218-4.
  75. Coordinator: Dr. M. Kirsch-Volders. Genotoxicity: The Micronucleus Test. Carcinogenic Risk In Occupational Settings (CRIOS). [Online] February 13, 2008. [Cited: November 7, 2014.]
  76. Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. Debourdeau, Philippe M., et al., et al. [ed.] Jr. Harvey A.K. Whitney. 4, Cincinnati: SAGE Publications, April 2001, Annals of Pharmacotherapy, Vol. 35, pp. 424-426. DOI: 10.1345/aph.10213; ISSN: 1060-0280.
  77. Trivieri, Larry and Anderson, John W. Alternative Medicine: The Definitive Guide. 2nd. New York: Random House, Inc.: InnoVision Health Media, Inc., 2002. ISBN: 978-1-58761-141-4.
  78. Getty, Juliet M. Feed Your Horse Like a Horse: Optimize Your Horse's Nutrition for a Lifetime of Vibrant Health. Indianapolis: Dog Ear Publishing, 2009. ISBN: 978-160844-214-0.
  79. Frape, David. Equine Nutrition and Feeding. 4th. Chicester: John Wiley and Sons, 2010. ISBN: 978-1-4051-9546-1.
  80. Duncanson, Graham R. Veterinary Treatment for Working Equines. Cambridge: CABI, 2010. ISBN-13: 978-1-84593-655-6.
Protected by Copyscape Online Copyright Search